NasdaqGM - Delayed Quote USD

Global X Genomics & Biotechnology ETF (GNOM)

9.80 +0.11 (+1.13%)
At close: April 26 at 4:00 PM EDT

Top 10 Holdings (45.06% of Total Assets)

SymbolCompany% Assets
NTRA
Natera, Inc. 7.23%
CRSP
CRISPR Therapeutics AG 5.51%
RARE
Ultragenyx Pharmaceutical Inc. 4.50%
A
Agilent Technologies, Inc. 4.46%
MRNA
Moderna, Inc. 4.40%
BEAM
Beam Therapeutics Inc. 3.91%
SRPT
Sarepta Therapeutics, Inc. 3.83%
ILMN
Illumina, Inc. 3.82%
ARWR
Arrowhead Pharmaceuticals, Inc. 3.77%
TECH
Bio-Techne Corporation 3.64%

Sector Weightings

SectorGNOM
Healthcare   100.00%
Real Estate   0.00%
Technology   0.00%
Utilities   0.00%
Industrials   0.00%
Energy   0.00%

Overall Portfolio Composition (%)

Stocks 99.98%
Bonds 0.00%

Equity Holdings

Price/Earnings 0
Price/Book 0.31
Price/Sales 0.14
Price/Cashflow 0
Median Market Cap --
3 Year Earnings Growth --

Bond Ratings

US Government 0.00%
AAA --
AA --
A --
BBB --
BB --
B --
Below B --
Other --

ETF Summary

The fund invests at least 80% of its total assets in the securities of the underlying index. The underlying index is designed to provide exposure to exchange-listed companies that are positioned to benefit from further advances in the field of genomic science and biotechnology, as well as applications thereof (collectively, "Genomics & Biotechnology Companies"), as defined by Solactive AG, the provider of the underlying index. The fund is non-diversified.

ETF Overview

Category Health
Fund Family Global X Funds
Net Assets 103.57M
YTD Daily Total Return -15.21%
Yield 0.00%
Legal Type Exchange Traded Fund

Related Tickers